AMETEK, Inc. (NYSE:AME) insider Tony J. Ciampitti sold 9,534 shares of AMETEK stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $97.14, for a total transaction of $926,132.76. Following the transaction, the insider now owns 42,979 shares in the company, valued at approximately $4,174,980.06. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
AME opened at $96.54 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.48 and a current ratio of 2.05. AMETEK, Inc. has a fifty-two week low of $63.14 and a fifty-two week high of $97.30. The firm’s fifty day moving average is $90.22 and its 200 day moving average is $87.83. The stock has a market cap of $22.00 billion, a price-to-earnings ratio of 29.34, a price-to-earnings-growth ratio of 2.13 and a beta of 1.20.
AMETEK (NYSE:AME) last announced its quarterly earnings results on Thursday, October 31st. The technology company reported $1.06 EPS for the quarter, topping the consensus estimate of $1.01 by $0.05. The business had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.28 billion. AMETEK had a net margin of 16.63% and a return on equity of 20.04%. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.91 EPS. On average, equities research analysts predict that AMETEK, Inc. will post 4.14 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.58%. AMETEK’s payout ratio is currently 17.02%.
AME has been the topic of a number of analyst reports. Oppenheimer lifted their target price on shares of AMETEK from $94.00 to $100.00 and gave the company an “outperform” rating in a research note on Wednesday, July 31st. Rosenblatt Securities initiated coverage on shares of AMETEK in a research note on Thursday. They set a “buy” rating and a $115.00 target price on the stock. KeyCorp lifted their target price on shares of AMETEK from $94.00 to $100.00 in a research note on Wednesday, July 31st. Morgan Stanley set a $102.00 target price on shares of AMETEK and gave the company a “buy” rating in a research note on Friday, November 1st. Finally, Royal Bank of Canada set a $95.00 target price on shares of AMETEK and gave the company a “buy” rating in a research note on Wednesday, July 31st. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $97.62.
Hedge funds have recently made changes to their positions in the business. NumerixS Investment Technologies Inc purchased a new stake in AMETEK in the 2nd quarter worth $27,000. Shine Investment Advisory Services Inc. lifted its stake in AMETEK by 67.8% in the 3rd quarter. Shine Investment Advisory Services Inc. now owns 302 shares of the technology company’s stock worth $28,000 after purchasing an additional 122 shares in the last quarter. Capital Bank & Trust Co purchased a new stake in AMETEK in the 2nd quarter worth $29,000. Berman Capital Advisors LLC lifted its stake in AMETEK by 51.3% in the 2nd quarter. Berman Capital Advisors LLC now owns 454 shares of the technology company’s stock worth $41,000 after purchasing an additional 154 shares in the last quarter. Finally, Ibex Wealth Advisors purchased a new stake in AMETEK in the 2nd quarter worth $52,000. Institutional investors and hedge funds own 86.51% of the company’s stock.
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.